Brian Oneill, MD
Orthopaedic Surgery · Robbinsdale, MNNPI 1700897162
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $18,450 of the $24,830 with a category attached, or 74.3%. Medical Device Business Services, Inc. accounts for 74.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $8,856 and has fallen 62.0% since, to $3,364 in 2023.
Across 29 payments — averaging $856.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$19K
- Conformis, Inc.$5K
- Johnson & Johnson$892
- Linvatec Corporation$162
- Smith+Nephew$85
Across 7 payments — averaging $51,796 each. An ownership or investment interest held by the physician or an immediate family member.
- Responsive Arthroscopy Inc$363K
What the payments were for
- Consulting fees$18,45074%
- Speaking & faculty fees$3,17813%
- Travel & lodging$2,41210%
- Food & beverage$7903%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 11 | $18,550 |
| Conformis, Inc. | 13 | $5,142 |
| Johnson & Johnson | 3 | $892 |
| Linvatec Corporation | 1 | $162 |
| Smith+Nephew | 1 | $85 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GLOBAL$16,200
- EXPAREL$16,200
- BIOLOX DELTA$9,900
- DELTA$8,550
- HP PARTIAL$8,550
- SIGMA$7,650
- Actera Hip Stem$3,884
- Hip$1,070
- iTotal Identity PS$1,070
- BioBrace 23mm$162
How this compares
$24,830 in reported general payments places this provider in the 80th percentile of 533 orthopaedic surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 30 | $823 |
| Oxycodone Hcl | 50 | $282 |
| Amoxicillin | 72 | $152 |
| Pantoprazole Sodium | 11 | $86 |
| Pregabalin | 13 | $77 |
| Tramadol Hcl | 15 | $30 |
| Doxycycline Hyclate | 17 | $12 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Robbinsdale
- Paul CammackRobbinsdale$154K
- Daniel BerryRochester$21.5M
- Mark PagnanoRochester$14.8M
- Robert TrousdaleRochester$12.2M
- John SperlingRochester$12.2M
- Shawn O'DriscollRochester$10.5M
- Bryan Den HartogStillwater$9M
- Joseph NesslerSartell$8.6M
- David LewallenRochester$8M
- Rafael SierraRochester$4.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.